D10.39 Benign neoplasm of other parts of mouth

✓ Billable ICD-10-CM 2026
Open D10.39 in Web App →

The ICD-10-CM code for Benign neoplasm of other parts of mouth is D10.39 (FY2026). It is a billable, claim-ready diagnosis code.

Classification

Section
D10-D36: Benign neoplasms, except benign neuroendocrine tumors (D10-D36)
Category D10
12 codes (10 billable)
FY2026 Status
Stable since FY2024

Also Known As

ICD-10-CM Alphabetic Index entries that lead to D10.39:

  • Nevus › oral mucosa › specified site NEC
  • Nevus › mouth (mucosa) › specified site NEC
Excludes1
Not coded here. These conditions should NOT be coded together with D10.39.
  • benign odontogenic neoplasms (D16.4-D16.5)
  • benign neoplasm of mucosa of lip (D10.0)
  • benign neoplasm of nasopharyngeal surface of soft palate (D10.6)

Inclusion Terms

  • Benign neoplasm of minor salivary gland NOS

U.S. Hospital Utilization

  • An estimated 105 U.S. inpatient stays in 2023 included D10.39 among the documented diagnoses.

Source: National Inpatient Sample (NIS), Healthcare Cost and Utilization Project (HCUP), Agency for Healthcare Research and Quality, 2016–2023. National survey-weighted estimates.

Official Coding Guidelines

Tx of primary site (TOC entry)

a. Admission/Encounter for treatment of primary site ............................................................. 33

— ICD-10-CM Official Guidelines for Coding and Reporting, FY2026, Section I.C.2.a
Tx of secondary site (TOC entry)

b. Admission/Encounter for treatment of secondary site .......................................................... 33

— ICD-10-CM Official Guidelines for Coding and Reporting, FY2026, Section I.C.2.b

Source: CMS — ICD-10-CM Official Guidelines for Coding and Reporting, FY2026

References

Related Codes

Search all 70,000+ ICD-10-CM codes →
Reviewed by Prajwal Shrestha, CPC, CRC
Certified Professional Coder (CPC) and Certified Risk Adjustment Coder (CRC) · AAPC Member ID 01997614 · About · Editorial policy · Content last reviewed: 2025-10-01

Get HCC Mappings, Clinical Summaries, and More

Access premium features including HCC risk adjustment, FDA drug indications, AI coding assistant, and comprehensive clinical context.

Start Free Trial